Bioconjugate & ADC Process Development - Abzena

PEGS Summit 2025

Boston, MA, USA | May 12-16, 2025

PEGS Summit 2025

Are you planning to attend the essential Protein & Antibody Engineering Summit 2025 in Boston, MA between May 12-16, 2025?

If so, make sure to connect with Abzena at the event. Our antibody engineering experts will be on hand to discuss all your biologics discovery, development and manufacturing needs.

Event Details:

Dates: May 12-16
Location: Boston, MA, USA
Event website: PEGS Summit 2025

Learn how our antibody design and protein engineering teams can de-risk your biologic development program. Abzena collaborate and work to give you the best chance of success by combining over 20 years of protein engineering with state-of-the-art analytics services.

We can provide you with an update on our expanded global capabilities and enhanced platform technology like AbZelectPRO™, our enhanced cell line development solution. AbZelectPRO™ can take you from DNA to RCB in 10 weeks with 8g/L in high-performing titers. If you are ready to achieve more from your cell line and reach IND faster, discover AbZelectPRO™.

At PEGS Boston, Abzena and our expert speaker will be hosting a presentation which we invite you to attend to find out more about our services and our latest insights…

Edward Cloake, Director, Immunology
‘In silico immunogenicity analysis in the developability of biologics are complemented and enhanced by data-rich ex vivo assays’
Immunogenicity Track

May 13 at 3:45 pm

Complete the form below to schedule a meeting and learn how Abzena’s integrated solutions can help accelerate your biologic drug development journey.

Schedule a meeting with our experts at PEGS Summit 2025


 

About Abzena

Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. We have research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.

Meet our team

Edward Cloake

Director, Immunology

Campbell Bunce

Chief Scientific Officer (CSO)

Upcoming events